CN Patent

CN101069681A — 含有布洛芬的注射剂及其制备方法

Assigned to Individual · Expires 2007-11-14 · 19y expired

What this patent protects

本发明提供了一种含有布洛芬注射剂及制备方法，该制剂克服传统口服布洛芬制剂如片剂、胶囊、分散片、口服混悬液等普通制剂，存在的溶解度小、吸收慢、生物利用度低、起效相对较慢的不足，以及对儿童、老年人和不能吞服固体制剂的患者带来不便；该制剂解决了产品溶解性及给药途径问题，所得的产品质量稳定、生物利用度高、起效迅速的优点。

USPTO Abstract

本发明提供了一种含有布洛芬注射剂及制备方法，该制剂克服传统口服布洛芬制剂如片剂、胶囊、分散片、口服混悬液等普通制剂，存在的溶解度小、吸收慢、生物利用度低、起效相对较慢的不足，以及对儿童、老年人和不能吞服固体制剂的患者带来不便；该制剂解决了产品溶解性及给药途径问题，所得的产品质量稳定、生物利用度高、起效迅速的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN101069681A
Jurisdiction
CN
Classification
—
Expires
2007-11-14
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.